Company Filing History:
Years Active: 2016-2024
Title: Wilhelmus Johannes Antonius Kersten: Innovator in Pharmaceutical Compounds
Introduction
Wilhelmus Johannes Antonius Kersten is a notable inventor based in Bundoora, Australia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential applications in treating cancer and hemoglobinopathies. With a total of four patents to his name, Kersten's work exemplifies innovation in medicinal chemistry.
Latest Patents
Among his latest patents, Kersten has developed a compound of formula (I), which includes a pharmaceutically acceptable salt. This compound features 2-(hetero)aryl-benzimidazole and imidazopyridine derivatives that act as inhibitors of asparagine methyl transferase. The specific structures involve substituted benzimidazole and 3H-imidazo[4,5-b]pyridines, where various groups are selected to enhance their pharmaceutical efficacy. These compounds are particularly promising for their use in treating serious medical conditions.
Career Highlights
Throughout his career, Kersten has worked with several companies, including Cancer Therapeutics CRC Pty Limited and Ctxt Pty Limited. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in pharmaceuticals.
Collaborations
Kersten has collaborated with notable professionals such as Richard Charles Foitzik and Michelle Ang Camerino. These partnerships have further enriched his research and development efforts, leading to innovative solutions in the pharmaceutical industry.
Conclusion
Wilhelmus Johannes Antonius Kersten stands out as a significant figure in the realm of pharmaceutical innovation. His contributions through patents and collaborations highlight his commitment to advancing medical science.